🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › Utah › Salt Lake City

Uji klinis Kelebihan Berat Badan di Salt Lake City, UT

13 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Pantheon Clinical Research, Bountiful · 9 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07684235

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Salt Lake City
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON Early Phase Services, LLC, Salt Lake City
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725

Circadian Intervention to Improve Cardiometabolic Health

Menerima pesertaSukarelawan sehat diterima
  • College of Health Research Complex--University of Utah, Salt Lake City
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT05943626

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

Menerima pesertaSukarelawan sehat diterima
  • College of Health Research Complex--University of Utah, Salt Lake City
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06180837

Testing a Tailored Approach to Long-Term Weight Loss Success

Menerima pesertaSukarelawan sehat diterima
  • University of Utah, Salt Lake City
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07577765

The Acute T-Rex (Timing of Resistance Exercise) Study

Menerima peserta
  • University of Utah HPER E Buildling, Salt Lake City
Usia 50 hingga 74 · Semua jenis kelamin · Diperbarui 3 Apr 2025 · NCT06366399

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Salt Lake City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.